Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Crews

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
RSC Chemical Biology|July 2, 2021
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradationMichael J Bond, Craig M Crews
Current Opinion in Chemical Biology|April 21, 2019
Targeted protein degradation: elements of PROTAC designStacey-Lynn Paiva, Craig M Crews
Methods in Molecular Biology (Clifton, N.J.)|March 6, 2015
Generating and identifying axolotls with targeted mutations using Cas9 RNA-guided nucleaseG Parker Flowers, Craig M Crews
Journal of Medicinal Chemistry|May 21, 2016
Inducing Protein Degradation as a Therapeutic StrategyCraig M Crews, Gunda Georg, Shaomeng Wang
Developmental Cell|July 11, 2003
Chemical genetics: adding to the developmental biology toolboxJing-Ruey J Yeh, Craig M Crews
Cell Chemical Biology|May 18, 2021
Targeted protein degradation: A promise for undruggable proteinsKusal T G Samarasinghe, Craig M Crews
ACS Chemical Biology|December 30, 2008
Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than OneTimothy W Corson, Nicholas Aberle, Craig M Crews
Nature Reviews. Drug Discovery|January 19, 2022
PROTAC targeted protein degraders: the past is prologueMiklós Békés, David R Langley, Craig M Crews
Nature Reviews. Clinical Oncology|February 13, 2023
Protein degraders enter the clinic - a new approach to cancer therapyDeborah Chirnomas, Keith R Hornberger, Craig M Crews
Chemical Communications (Cambridge, England)|June 11, 2020
Scaffold hopping enables direct access to more potent PROTACs with in vivo activityGeorge M Burslem, Daniel P Bondeson, Craig M Crews
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
RSC Chemical Biology|July 2, 2021
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradationMichael J Bond, Craig M Crews
Current Opinion in Chemical Biology|April 21, 2019
Targeted protein degradation: elements of PROTAC designStacey-Lynn Paiva, Craig M Crews
Methods in Molecular Biology (Clifton, N.J.)|March 6, 2015
Generating and identifying axolotls with targeted mutations using Cas9 RNA-guided nucleaseG Parker Flowers, Craig M Crews
Journal of Medicinal Chemistry|May 21, 2016
Inducing Protein Degradation as a Therapeutic StrategyCraig M Crews, Gunda Georg, Shaomeng Wang
Developmental Cell|July 11, 2003
Chemical genetics: adding to the developmental biology toolboxJing-Ruey J Yeh, Craig M Crews
Cell Chemical Biology|May 18, 2021
Targeted protein degradation: A promise for undruggable proteinsKusal T G Samarasinghe, Craig M Crews
ACS Chemical Biology|December 30, 2008
Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than OneTimothy W Corson, Nicholas Aberle, Craig M Crews
Nature Reviews. Drug Discovery|January 19, 2022
PROTAC targeted protein degraders: the past is prologueMiklós Békés, David R Langley, Craig M Crews
Nature Reviews. Clinical Oncology|February 13, 2023
Protein degraders enter the clinic - a new approach to cancer therapyDeborah Chirnomas, Keith R Hornberger, Craig M Crews
Chemical Communications (Cambridge, England)|June 11, 2020
Scaffold hopping enables direct access to more potent PROTACs with in vivo activityGeorge M Burslem, Daniel P Bondeson, Craig M Crews
Pageof 16